Samlet overlevelse er vist i studie E4599 med en dosering af bevacizumab på 15 mg/ kg legemsvægt hver 3. uge.
An overall survival benefit has been demonstrated in study E4599 with a 15 mg/ kg/ q3wk dose of bevacizumab.